| NCT05491525 | A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC | Urovant Sciences GmbH | | - Age 2 - 17 yrs
- Level -
AIS - ≥ 6 months
- Diagnosed with Neutrogenic Detrusor Overactivity
- NO cerebral palsy, uncontrolled epilepsy, diabetes insipidus, or Stage 2 hypertension
| Recruiting | 85 | PHASE2, PHASE3 | Drug | Bladder health/function | | | 12 October 2022 | 08 August 2022 | 6 | |
| NCT05502614 | Dorsal Genital Nerve Stimulation for Bladder Management After SCI | University College, London | | - Age ≥ 18 yrs
- Level -
AIS A, B, C, D- ≥ 6 months
- Neurogenic detrusor overactivity
| Active | 10 | NA | Technology | Bladder health/function | - Incontinence Quality of Life Questionnaire (I-QOL)
- Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0)
| 13 weeks | 23 January 2023 | 16 August 2022 | 1 | |
| NCT05513911 | Intermittent Hypoxia and Upper Extremity EMG Recordings in Individuals With Spinal Cord Injury | Shirley Ryan AbilityLab | | - Age 18 - 70 yrs
- Level C3-T4
AIS - ≥ 6 months
| Ended | 8 | NA | Drug | Arm/hand function | - Surface Electromyography (sEMG)
| | 03 February 2016 | 24 August 2022 | 1 | |
| NCT05515419 | Allogeneic Cord Blood for Neurological Diseases in Adults | The Medical Pavilion Bahamas | | - Age ≥ 18 yrs
- Level -
AIS - ≤ 24 months
| Ended | 0 | EARLY_PHASE1 | Biological/cell based | Mental health and psychosocial factors | | 12 months | 01 July 2025 | 25 August 2022 | 0 | |
| NCT05390853 | Active tDCS Versus Sham tDCS for Upper Limb Recovery in Incomplete Tetraplegic Patients | Montecatone Rehabilitation Institute S.p.A. | | - Age 18 - 74 yrs
- Level C3-C7
AIS B, C, D- 3 months - 6 months
- NOT having any implanted devices (e.g. pacemakers, intrathecal infusers, neurostimulators, hearing aids
- NOT having any history of brain lesions
- NOT having a history of epilepsy
- NOT having a history of psychotic disorders
- NOT having a history of severe neurodegenerative disease
- NOT having a brain tumor
| Recruiting | 30 | NA | Technology | Arm/hand function | - Ashworth and Modified Ashworth Scale (MAS)
- Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)
- Numeric Pain Rating Scale
| 10 Weeks | 24 May 2023 | 25 May 2022 | 1 | |
| NCT05302999 | Feasibility of Early Gabapentin as an Intervention for Neurorecovery | MetroHealth Medical Center | | - Age ≥ 18 yrs
- Level C1-S5
AIS A, B, C, D, E- ≥ null null
- NOT have suffered a moderate/severe traumatic brain injury (TBI)
| Recruiting | 42 | PHASE4 | Drug | General health | | 6 months | 14 March 2022 | 31 March 2022 | 1 | |
